Last reviewed · How we verify
Vehicle Sterile Solution
Vehicle Sterile Solution is a Small molecule drug developed by Allergan. It is currently FDA-approved for Vehicle/control formulation for ophthalmic drug delivery.
Vehicle Sterile Solution is an inert carrier formulation used as a control or diluent in ophthalmic drug delivery systems.
Vehicle Sterile Solution, also known as MVC-101, is being studied in clinical trials for various conditions including solid tumors and neurotrophic keratopathy. The exact mechanism of action of Vehicle Sterile Solution is unknown.
At a glance
| Generic name | Vehicle Sterile Solution |
|---|---|
| Sponsor | Allergan |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
This is a sterile, pharmaceutical-grade solution designed to serve as a vehicle for ophthalmic medications or as a control comparator in clinical studies. It contains no active pharmaceutical ingredient and functions primarily as a delivery medium or placebo formulation for eye-related applications.
Approved indications
- Vehicle/control formulation for ophthalmic drug delivery
Common side effects
Key clinical trials
- A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). (PHASE1, PHASE2)
- An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations (PHASE3)
- The Safety and Efficacy of SYD-101 in Children With Myopia (PHASE3)
- Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 (PHASE3)
- Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PHASE3)
- Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances (PHASE3)
- Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease (PHASE2)
- Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vehicle Sterile Solution CI brief — competitive landscape report
- Vehicle Sterile Solution updates RSS · CI watch RSS
- Allergan portfolio CI
Frequently asked questions about Vehicle Sterile Solution
What is Vehicle Sterile Solution?
How does Vehicle Sterile Solution work?
What is Vehicle Sterile Solution used for?
Who makes Vehicle Sterile Solution?
What development phase is Vehicle Sterile Solution in?
Related
- Manufacturer: Allergan — full pipeline
- Therapeutic area: All drugs in Ophthalmology
- Indication: Drugs for Vehicle/control formulation for ophthalmic drug delivery
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing